Louisa Jordison
Directeur Financier/CFO chez Sygnature Discovery Ltd.
Postes actifs de Louisa Jordison
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sygnature Discovery Ltd.
Sygnature Discovery Ltd. Pharmaceuticals: MajorHealth Technology Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom. | Directeur/Membre du Conseil | 01/01/2019 | - |
Directeur Financier/CFO | 01/01/2021 | - | |
SB Drug Discovery Ltd.
SB Drug Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sygnature Discovery Ltd., SB Drug Discovery Ltd. is a British company that specializes in ion channel services. The company is based in Glasgow, UK. The company offers a portfolio of electrophysiology assays and customized cell line development capabilities to aid in ion channel drug discovery. The company's services include ion channel screening, receptor and enzyme studies, and custom cell line generation expertise. The company also provides a comprehensive panel of sodium (Nav) channel cell lines and assays, as well as HTS and selectivity profiling services to advance hit-to-lead campaigns. The company was founded in 2002. SB Drug Discovery was acquired by Sygnature Discovery Ltd. on January 17, 2023. | Directeur/Membre du Conseil | 16/12/2022 | - |
Historique de carrière de Louisa Jordison
Statistiques
Internationale
Royaume-Uni | 3 |
Opérationnelle
Director/Board Member | 2 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Sygnature Discovery Ltd.
Sygnature Discovery Ltd. Pharmaceuticals: MajorHealth Technology Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom. | Health Technology |
SB Drug Discovery Ltd.
SB Drug Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sygnature Discovery Ltd., SB Drug Discovery Ltd. is a British company that specializes in ion channel services. The company is based in Glasgow, UK. The company offers a portfolio of electrophysiology assays and customized cell line development capabilities to aid in ion channel drug discovery. The company's services include ion channel screening, receptor and enzyme studies, and custom cell line generation expertise. The company also provides a comprehensive panel of sodium (Nav) channel cell lines and assays, as well as HTS and selectivity profiling services to advance hit-to-lead campaigns. The company was founded in 2002. SB Drug Discovery was acquired by Sygnature Discovery Ltd. on January 17, 2023. | Commercial Services |
- Bourse
- Insiders
- Louisa Jordison
- Expérience